Clinical Trial Update: Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and tolerability of repeated oral dosing with AZD1656 in adults with type 2 diabetes mellitus on metformin has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2012-11-16